Screenmedsp. z o.o.

Wholesale of pharmaceutical goods

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2015-09-15
Share capital
5 000,00 PLN
Activity description

Screenmed is a leading Polish manufacturer and distributor of medical diagnostic tests, devices, and accessories. They offer a range of diagnostic tests including Strep A, flu, CRP, and RSV tests, as well as various analyzers such as POC, biochemical, hematological, and immunochemical analyzers. Additionally, they provide accessories like control materials, pipettes, lancing devices, and sample collection kits.

Registered address
ul. Okulickiego 5F, 05-500 Piaseczno, Poland
Website
screenmed.plWebsite active
Email
Email address current
Phone
Electronic delivery address
AE:PL-58696-31756-TSIUV-14

Financials

The financial statement for 2025 has not yet been filed with the Financial Document Repository (past deadline).

Revenue history (in k)

Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2024.

Results vs industry

Revenue
This companyUSD 147.40kMedianUSD 872.66kAverageUSD 20.23m
Net profit
This companyUSD -12.00kMedianUSD 28.28kAverageUSD 810.66k
Operating costs
This companyUSD 156.13kMedianUSD 799.89kAverageUSD 19.02m
Assets
This companyUSD 170.82kMedianUSD 539.29kAverageUSD 10.84m

Industry

Bank accounts

Registered as a VAT taxpayer on 2018-09-13. Active

  • mBank
    mBank
    04 1140 1977 0000 5668 3600 1001
  • mBank
    mBank
    51 1140 2004 0000 3012 0679 4681
  • mBank
    mBank
    20 1140 1977 0000 5668 3600 1004

Debt

No entries in the National Debtors Register (KRZ). No proceedings in KRZ

Public aid

12 public aid cases recorded, with a total value of $3,549,900.

PurposeGross amount
Aid for research and development projects: industrial research
$1.2M
Aid for research and development projects: experimental development
$138.7K
Aid for research and development projects: industrial research
$717.8K

European Funds

ProjectEU co-financing
Funkcjonalizowane nanocząstki magnetokatalityczne w systemach lab-on-foil i mikrofluidyce cyfrowej do detekcji biomarkerów medycznych (StepDiag)
$2.2M
Opracowanie konstrukcji i technologii wytwarzania miniaturowych urządzeń diagnostycznych do szybkiego wykrywania wirusa SARS-CoV-2 w trybie POCT.
$1.7M

Tenders

1 tender recorded as contractor, with a total value of $2,350.

SubjectAmount
Zakup sprzętu medycznego: Wideolaryngoskop intubacyjny z torem wizyjnym, Aparat transportowy, Tromboelastograf z kasetami pomiarowymi, Analizoator covid – 19 wraz z testami
$2,350

Authorized Representatives

Magdalena Maria Nowińska – President of the Management Board

Manner of representation

In the case of a one-person management board, declarations on behalf of the company are made by the member of the management board. In the case of a management board consisting of two or more persons, joint action by two members of the management board or by one member of the management board jointly with a commercial proxy is required to make declarations on behalf of the company.

Ownership

OwnerSharesShare valueStake
Magdalena Maria Nowińska (56)
50$675.3150%
Adam Nowiński (55)
50$675.3150%

Adam Nowiński and Magdalena Maria Nowińska hold a combined 100% – the ownership structure indicates family control.

Beneficial owners

Person
Magdalena Maria Nowińska (56)
Adam Nowiński (55)

Competitors

Name
Hemab Polskasp. z o.o.
Polygensp. z o.o.
Zakmed sp. z o.o.sp. k.
Madmedsp. z o.o.
Labmed Solutionssp. z o.o.
Scanmatsp. z o.o.
Aimedicalsp. z o.o.
BL Medicasp. z o.o.
Mimic Polandsp. z o.o.
Magna Superstessp. z o.o.

Change history

DateEvent
2017-11-27Address change
2015-09-15Entered in the register

FAQ

Last updated: 2026-07-15